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The occurrence of cancer during childhood represents one of the leading causes of death within the pediatric and adolescent age group. It is esti-
mated that approximately 8000 children will be diagnosed annually with cancer in the United States. Epidemiologic research addressing the etiology
of childhood cancer has been limited because of the difficulties in identifying a sufficiently large study population. Moreover, the use of retrospec-
tively ascertained childhood cancer cases in epidemiologic investigations has restricted the incorporation of biological and clinical parameters. The
Childrens Cancer Group has developed an active program in epidemiologic research, with over a decade of experience demonstrating the feasibility
and strengths of conducting analytic epidemiologic studies within a cooperative clinical trials network. The availability of detailed clinical and biologic
data on cases diagnosed within the cooperative group facilitates the transfer of state-of-the-art technology to epidemiologic research. - Environ
Health Perspect 103(Suppl 6):111-116 (1995)
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Introduction
Approximately 8000 children in the United
States are diagnosed annually with cancer
(1). The incidence of cancer in children less
than 15 years ofage is approximately 13 per
100,000 for whites and 11 per 100,000 for
blacks. While the absolute number ofchild-
hood cancer cases is low, when compared to
the number ofadult cancers, U.S. mortality
data demonstrate that cancer is the second
leading cause ofdeath in children, second
only to accidents (2). It can be estimated
that approximately one in every 400 indi-
viduals living in the United States will
develop cancer before age 15.
Data from the Surveillance Epidemi-
ology and End Results Program indicate a
gradual but continuous increase in the
incidence rates ofchildhood cancers (3,4).
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These increases are most apparent for
leukemia and brain tumors, the two diag-
noses that comprise approximately 50% of
cases in the 0 to 14 age group. There has
been considerable speculation on the
cause(s) ofthe observed increase. Possibili-
ties include random variations in the pat-
tern ofoccurrence ofcancer, improvements
in access to medical care and/or medical
detection, more complete case ascertain-
ment by registries, new or more extensive
environmental exposures, or iatrogenically
induced secondary cancers. A recent analysis
has demonstrated that secondary cancers do
not account for the increase (5).
The types and distributions of the
malignancies seen in the pediatric and ado-
lescent age groups differ substantially from
those seen in adults. Although childhood
cancers represent less than 2% ofall cancers
that occur in the United States, the unique
clinical and biologic features ofpediatric
malignancies have contributed substan-
tially to our understanding ofcancer. Most
ofthe contribution ofpediatric cancers has
been in providing insights into the genetic
events associated with malignant transfor-
mation. Tumor suppressor genes, first
identified in retinoblastoma (a tumor with
an annual incidence ofless than 5 per mil-
lion), have now been described in Wilms'
tumor, rhabdomyosarcoma, and some adult
malignancies (6-8). Childhood cancers have
also provided important information on
familial cancer associations and syndromes
(9-10). In contrast to these genetic and
familial findings, childhood cancers have
contributed much less to the understand-
ingofthe environmental aspects ofcancer.
Recognizing the difficulties ofconduct-
ing epidemiologic studies of childhood
cancer, the Childrens Cancer Group (CCG)
established an Epidemiology Committee to
propose and develop a program for con-
ducting studies within the structure ofthe
existing clinical trials cooperative group.
Following is a summary of the program
that currentlyexists in CCG.
The Childrens Cancer Group
Epidemiology Program
The Division of Cancer Therapy of the
National Cancer Institute supports a pro-
gram ofcollaborative cooperative clinical
trials groups. Presently there are two pedi-
atric groups, Childrens Cancer Group and
Pediatric Oncology Group. Collectively,
the members ofthese two large multi-insti-
tutional programs diagnose and treat
greater than 90% of cases of childhood
cancer in the United States and essentially
100% ofcases diagnosed before 5 years of
age (11). It is a requirement in CCG that
all pediatric oncology patients seen at a
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member institution be registered with the
group Operations Office, whether or not
the patient is entered into a clinical trial.
Recognizing the limitations imposed by
the relative rarity ofchildhood cancers and
the strengths of the cooperative group
mechanism, the CCG initiated develop-
ment of a program to conduct epidemio-
logic research within the existing clinical
trials infrastructure. The CCG Epidemiol-
ogy Committee functions as the primary
source ofexpertise in areas related to child-
hood cancer etiology and the conduct of
epidemiologic/etiologic investigations. The
overall objectives of the Epidemiology
Committee are to investigate environmental
and genetic factors related to childhood can-
cer etiology. The committee is responsible
for establishing long-range strategies and
priorities, initiating new proposals, review-
ing proposed study concepts, preparing and
submitting study-specific grant applications,
protocol development, monitoring study
progress, and reporting and publishing
study results. Close collaboration with the
clinical and other CCG committees (e.g.,
study committees, strategy groups, and
discipline and scientific committees) is
required to carry out these functions.
Previous and CurrentActivities
Since the Epidemiology Committee was
established in 1982, CCG has initiated 17
epidemiologic protocols and has proposed
Table 1. Summary of Childrens Cancer Group epidemiolog
three studies (Table 1). The majority of
CCG epidemiology studies have been
case-control designs. A methodology has
been successfully established (Figure 1) using
telephone interviews with parents ofcases
and controls. Controls are selected using a
method ofrandom digit dialing (12).
The 12-year history of the CCG
Epidemiology Committee has clearly
demonstrated the feasibility and advantages
ofconducting epidemiologic research within
the CCG. These include a) identification of
large numbers ofcases, b) extremely high
participation rates, c) integration of clinical
and biologic data into study designs, and
d) the ability to compete successfully for
NIH and private research funding.
Using the large case population avail-
able from CCG, studies ofsome ofthe less
common pediatric tumors [e.g., hepato-
blastoma, retinoblastoma, acute myeloid
leukemia (AML), Ewing's sarcoma,
osteosarcoma] have been conducted.
Moreover, for common childhood cancers,
it has been possible to target studies within
distinct subsets ofcases [e.g., immunophe-
notype in acute lymphoblastic leukemia
(ALL), young age in brain tumors, etc.]. By
and large these studies would not have
been feasible outside ofa cooperative group
setting. Provided in Table 2 are the average
numbers of new patients registered each
month with the CCG Operations Office.
Status/ No. Source of
Protocol Title cases Chairperson funding
Completed
E-01 Case-control study of osteogenic sarcoma 200 T Pendergrass Local
E-02 Case-control study of hepatoblastoma 75 J Buckley Local
E-03 Case-control study of Ewing's sarcoma 170 L Robison NIH
E-05 Case-control study of ANLL 204 L Robison NIH
E-06 Case-control study ofWilms' tumora 240 A Olshan March of Dimes
E-07 Case-control study of retinoblastoma 270 A Meadows NIH
E-1 1 Twin concordance study 850 J Buckley ACS
E-12 Case-control study of PNET and astrocytoma 321 G Bunin NIH
Closed/analysis
E-04 Self-administered questionnaire 3500 J Buckley Local
E-08 Case-control study of non-Hodgkin's lymphoma 240 J Buckley NIH
E-09 Case-control study of infant leukemia 290 L Robison NIH
E-10 Case-control study of rhabdomyosarcomaa 300 S Grufferman NIH
E-16 Parental occupation and childhood cancer 3500 G Bunin March of Dimes
Active
E-13 Case-control study of Hodgkin's diseases 300 S Grufferman NIH
E-14 Case-control study of ANLL 600 M Steinbuch NIH
E-15 Case-control study of childhood ALL 1950 L Robison NIH
E-17 Role of EBV in Hodgkin's disease' 400 S Grufferman NIH
E-18 Case-control study of neuroblastomaa 640 A Olshan NIH
Proposed
Maternal diet in PNET G Bunin NIH
Etiology of 11q23 abnormalities L Robison Pending
Case-control study of germ cell tumors X Shu Pending
'Collaborative study with the Pediatric Oncology Group.
Identification of case
Letterto referring physician
Permission to contact parents
Initial letterto parents
Study description
Topics covered in interview
Consentforms
Telephone contact
Agreement to participate
Consent forms retrieved
Xr
Appointment
Mail interview guide
Telephone interview
Arrangements for home visits, environmental
sampling, bloods, etc. (as applicable)
Figure 1. General procedure for Childrens Cancer
Group case-control studies.
Experience in CCG has shown that
using the methodologic approach adopted,
case-control studies designed to test
specific hypotheses and/or generate
hypotheses within selected childhood
cancers can be successfully conducted.
Impressively high rates of participation
(both physician and parent) have been
achieved. For example, in the current
case-control study of childhood ALL (E-
15), where over 2300 cases have been
identified, permission to contact parents
was received from physicians of 98.4% of
eligible cases. Physician refusal occurred in
only 1.1% and parent refusal, via the
physician, in 0.5%. Of the parents con-
tacted, 97.5% participated in the study.
Using the method of random digit dialing
for control selection, the participation rate
in CCG studies has averaged approxi-
mately 80%.
In addition to the availability of the
large numbers of cases, one of the major
advantages of conducting epidemiologic
studies in CCG is the clinical and biological
data that can be incorporated into the
design of the epidemiologic investigation.
Table 3 summarizes the CCG epidemiol-
ogy studies incorporating the use of clini-
cal/biological data in the study design
and/or analysis.
Funding of CCG epidemiologic studies
has been successfully obtained through NIH
ROl-supported grants as well as private
Environmental Health Perspectives 1 12CHILDRENS CANCER GROUPEPIDEMIOLOGYPROGRAM
Table 2. Average monthly accrual of cases registered
with Childrens Cancer Group.
Cancertype No. cases
ALL 88
AML 21
Brain tumors 62
Neuroblastoma 23
Wilms' tumors 19
Soft tissue sarcoma 24
Lymphoma 38
Bone tumors 20
Retinoblastoma 5
Others 22
Total 323
foundations (i.e., American Cancer
Society, March of Dimes). All the 12 RO0
grant applications that have undergone the
NIH peer-review process have received pri-
ority ratings resulting in funding.
Completed CCGEpidemiology
Studies
Listed below are some of the findings of
completed epidemiology studies conducted
by CCG (13-29):
* Identified risk factors for retinoblas-
toma differed according to the two
nonfamilial forms studied (sporadic
heritable and nonheritable). Paternal
occupational exposure to metals was
associated with the sporadic heritable
form, while employment as a welder or
machinist was associated with an
increased risk of nonheritable retino-
blastoma. (CCG-E07)
* Gestational factors including exposure
to X-rays and use of morning sickness
medications were significantly associ-
ated with an increased risk of nonheri-
table retinoblastoma, while vitamin use
during the first trimester ofpregnancy
was associated with a decreased risk in
both nonfamilial forms of retinoblas-
toma. (CCG-E07)
* Risk of astrocytic glioma is associated
with a history of seizures and epilepsy
in first or second degree relatives
(OR=2.4). The association is strongest
when the relative experienced seizures
in childhood. (CCG-E12)
* Maternal intake of dietary substances
relevant to the nitrosamine hypothesis
in childhood brain tumors was not
found to be associated with an
increased risk for astrocytic glioma or
primitive neuroectodermal tumor
(PNET) in young children. However,
for PNET a protective effect existed for
vegetables, fruits, folate, and vitamin C,
Table 3. Clinical and biologic data utilized in CCG epi-
demiology studies.
Diagnosis Protocol Clinical/biologic data
All diagnoses E04 ALL immunophenotype
AML E05 FAB morphology,
cytogenetics
Retinoblastoma E07 Cytogenetics
NHL E08 Cytogenetics, histologic
subtypes, EBV, HIV
Infant leukemia E09 FAB morphology,
cytogenetics
Soft-tissue sarcoma E10 Histologic subtypes
Brain tumors E12 Histologic subtypes
HD E13 Histologic subtypes,
disease, stage, EBV
AML E14 FAB morphology,
immunophenotype,
cytogenetics
ALL E15 Immunophenotype,
cytogenetics
Neuroblastoma E18 n-myc, stage
and for use of multivitamins early in
pregnancy. (CCG-E12)
* For cases diagnosed before age 6, a
striking difference exists in identified
risk factors for cases of PNET versus
astrocytic glioma. (CCG-E12)
* A previously reported association
between parental cigarette smoking and
risk of rhabdomyosarcoma in offspring
was not confirmed. However, in utero
X-ray exposure is associated with a
significant increase in risk of rhab-
domyosarcoma. (CCG-E10)
* Parents' use of cocaine and marijuana
significantly increased the risk of
rhabdomyosarcoma in their children.
(CCG-E10)
* A consistent statistically significant
association was identified between
reported pesticide exposure and risk of
childhood AML (paternal occupation:
OR= 2.7, maternal occupation:
7 cases/0 controls; and household:
OR= 3.5). Risks were substantially
increased for AML cases diagnosed
before age 6 and for those with M4 or
M5 morphology. (CCG-E05)
* Paternal occupational exposure to sol-
vents and petroleum products was found
to be associated with a statistically
significant increased risk of AML.
(CCG-E05)
* An 11-fold increased risk ofAML was
found for reported maternal use of
mind-altering drugs (primarily mari-
juana) just prior to or during the index
pregnancy. Exposed cases were
significantly younger at diagnosis and
were predominantly of myelomono-
cytic or monocytic morphology.
(CCG-E05)
* Maternal alcohol consumption during
the index pregnancy is associated with
an increased risk ofAML, particularly
within the subgroup of cases with
M4/M5 morphology. (CCG-E05)
* Maternal history of fetal loss was
significantly associated with risk of
childhood ALL. Risk increased dramat-
ically in cases diagnosed at younger ages
(i.e., cases diagnosed before 2 years of
age: OR= 5.3 for any previous miscar-
riage; OR=24.8 for more than one pre-
vious miscarriage). (CCG-E04)
* When assessing the potential role of
parental occupation as a risk factor for
Wilms' tumor, elevated odds ratios were
found for paternal occupations as auto
mechanic and welder. The estimated
risks were highest for employment dur-
ing the preconception and pregnancy
periods. (CCG-E06)
* Wilms' tumor cases were significantly
more likely to have fathers employed in
occupations associated with solvent
exposure. (CCG-E04)
* Previously reported associations between
Wilms' tumor risk and parental occupa-
tional exposure to hydrocarbons and
lead were not confirmed. Similarly,
contrary to other reports in the litera-
ture, no associations were identified
between Wilms' tumor and a) maternal
tobacco, tea, and coffee consumption
during pregnancy, b) maternal hyper-
tension, hair dye use, or vaginal infec-
tion during pregnancy, c) in utero
exposure to exogenous hormones, or d)
increased birth weight. (CCG-E06)
* The hypothesis that maternal exposure
to potentially hepatotoxic agents
(including alcohol, chlorinated hydro-
carbons, nitrosamines, viruses, or
exogenous estrogens) would be associ-
ated with increased risk ofhepatoblas-
toma was tested and rejected. (CCG-
E02)
* Maternal occupational exposures to
metals (OR= 8.0), hydrocarbons
(OR= 3.7), and paints/pigments
(OR= 3.7) and paternal occupational
exposures to metals (OR= 3.0) and
petroleum products (OR= 1.9) were
associated with risk ofhepatoblastoma.
(CCG-E02)
* A multi-center/organization study
designed to determine zygosity and fre-
quency ofcancer concordance ofcancer
in twins confirmed the view that
inherited genetic factors play a minor
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role in most childhood cancers. In
malignancies other than retinoblastoma
and leukemia, only 3 of334 twins were
concordant for cancer. Three of 197
leukemia twins were concordant, as were
5 of 19 retinoblastomas. (CCG-E11)
Current CCGEpidemiologyStudies
Epidemiology ofHodgkin's Disease
(CCG-E13). This is the first interview
case-control study ofchildhood Hodgkin's
disease (HD). The study is designed to fill
several important gaps in knowledge by
investigating environmental exposures as
risk factors for childhood HD. This is a
collaborative study of the Pediatric
Oncology Group and CCG. The specific
aims ofthe CCG-E13 study are a) to eval-
uate whether, on epidemiologic grounds,
childhood HD is distinct from the young
adult and old adult diseases; b) to evaluate
the hypothesis that children with HD have
different patterns ofinfectious disease than
do matched controls; c) to assess day care
of children (with its attendant increased
risk ofinfectious diseases acquired at early
ages) as a risk factor for HD; d) to evaluate
the association between breastfeeding and
risk of HD; e) to evaluate the association
between indicators ofsocioeconomic status
and HD; f) to evaluate parental occupa-
tional exposures as risk factors for HD in
children; g) to evaluate environmental
exposures to wood and chemicals as possible
risk factors in children; h) to evaluate
familial aggregation of HD (and possibly
increased risk of other malignancies or
multiple sclerosis); i) to evaluate risk fac-
tors of HD separately for each histologic
subtype ofthe disease, and by disease stage
and age at diagnosis.
Epidemiology of Acute Myeloid
Leukemia (CCG-E14). This study is a fol-
lowup to CCG-E05, an analytic study
designed to assess specific environmental
exposures as risk factors for childhood
AML. Two of the strongest associations
from our previous study were with mater-
nal marijuana use and pesticide exposure
(using multivariate analyses, they were
found to be independently associated with
an increased risk). The primary objectives
ofthe study are a) to confirm the associa-
tion ofpesticide exposure and AML risk,
and to identify the substances) or class of
pesticide responsible for the association; b)
to confirm the association ofsolvents and
petroleum products and AML risk, and to
determine the class ofsolvent responsible;
c) to confirm the association of maternal
marijuana use and AML risk; d) to iden-
tify subgroups, defined by age at diagnosis,
FAB morphology, cytogenetic abnormality,
or clinical features of the leukemia, in
which associations with pesticide, solvent
or marijuana exposures are strongest.
Secondary aims are e) to further investigate
identified associations ofchildhood AML
and parental occupational exposures to
paints/pigments, sawdust, metal dusts and
fumes, plastics, and lead; and f) to assess a
possible association of an extended dura-
tion of use of morning sickness medica-
tions and an increased risk for childhood
AML.
Epidemiology ofAcute Lymphoblastic
Leukemia (CCG-E15). This study is
designed to investigate the role ofrisk fac-
tors for acute lymphoblastic leukemia
within biologically defined subgroups.
Because ofthe availability ofimmunophe-
notypic characteristics and cytogenetics for
all newly diagnosed cases, it will be possible
to identify biologically distinct subgroups
from all newly diagnosed children with
ALL. This case-control study will investi-
gate whether or not there are distinct risk
factors within subgroups of childhood
ALL. Risk factors to be investigated
include those relating to demographic
characteristics, preconception exposures of
parents, reproductive factors including
reproductive history, medical exposures
during pregnancy, illnesses, events sur-
rounding the labor and delivery, diet dur-
ing pregnancy, and possible occupational
exposures of mothers and fathers during
the index pregnancy, postnatal exposures
relating to parental occupations and gen-
eral environment, as well as a family med-
ical history. Additional objectives of this
study include assessment of exposure to
very low level electromagnetic fields with
indirect and direct measurements, assess-
ment of exposure to radon and gamma
radiation (direct measurements), and
measurement of exposure to household
pesticide residues (direct measurement).
Studies relating to electromagnetic field
radiation, radon, and gamma radiation are
being conducted in collaboration with
investigators from the National Cancer
Institute.
Parental Occupation and Childhood
Cancer (CCG-E16). This study uses the
unique data source that contains informa-
tion from a self-administered questionnaire
on 3549 children with cancer and 839
healthy children (E04). The cancers we
will study are acute lymphoblastic
leukemia, neuroblastoma, acute myeloid
leukemia, non-Hodgkin's lymphoma,
Hodgkin's disease, Wilms' tumor, osteosar-
coma, astrocytoma, primitive neuroecto-
dermal tumor (PNET)/medulloblastoma,
rhabdomyosarcoma, germ cell and gonadal
tumor, hepatoblastoma, Ewing's sarcoma,
and histiocytosis X. The following specific
hypotheses will be tested: a) children with
Wilms' tumor, brain tumor, and other
cancers are more likely than controls to
have parents who worked in metal-related
occupations or industries; b) children with
neuroblastoma, brain tumor, and other
cancers are more likely than controls to
have parents employed in the electric and
electronic industry; c) children with brain
tumor, acute myeloid leukemia, and other
cancers are more likely than controls to
have parents employed in agriculture or
occupations with exposure to pesticides.
Epidemiology of Neuroblastoma
(CCG-E18). The major purpose of the
CCG-E18 study is to examine the relation-
ships between specific environmental expo-
sures and the occurrence ofneuroblastoma.
The specific aim ofthe study is to evaluate
hypothesized risk factors, including mater-
nal use of drugs, sex hormones, alcohol,
and diuretics during pregnancy. The analy-
sis ofmaternal drug use during pregnancy
will include a special evaluation of the
potential for these drugs to result in
transplacental N-nitroso compound expo-
sure. In addition, paternal employment in
the electronics industry and occupational
exposure to electromagnetic fields will be
examined. Other risk factors previously
found to be associated with neuroblastoma
such as maternal age, length ofgestation,
birth weight, and family socioeconomic
status will be evaluated. In addition, this
study will collect information on addi-
tional potential risk factors that may be
used to develop new etiologic hypotheses
(such as family medical history, neonatal,
gestational, and delivery history, and
household environmental exposures); and
evaluate the above potential risk factors
separately for subgroups ofpatients defined
by clinical, biologic, and genetic markers
such as cytogenetic abnormality and n-myc
oncogene amplification.
Current and Future
Research Objectives
Through continued reliance on externally-
funded investigations (primarily RO1
grants), the CCG Epidemiology Commit-
tee plans to increase further the focus and
complexity offuture epidemiologic studies
conducted within CCG by a) concentrat-
ing efforts on more detailed testing of
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specific hypotheses, b) greater integration
of biologic parameters, and c) including
more quantitative measures ofexposure.
Part ofthe future strategy ofthe CCG
Epidemiology Committee is to continue to
perform detailed assessments of associa-
tions identified in previous CCG epidemi-
ologic studies. Through the series of
case-control studies that have been success-
fully conducted within CCG, associations
have been identified that require confirma-
tion and further elucidation. For example,
the CCG-E05 study found pesticide expo-
sures and maternal drug use to be
significantly associated with an increased
risk of childhood AML, particularly M4
and M5 morphologies. Since the E05
study represented the first large case-con-
trol study ofchildhood AML, the interview
included a wide range oftopics, thus limit-
ing the degree of detail that could be
obtained about factors ofinterest. Based on
the results, NIH funded a case-control
study of 550 cases of childhood AML
designed to test a series ofhypotheses relat-
ing to pesticide exposures and maternal
marijuana use. In the future, it is antici-
pated that followup studies will be pro-
posed based on the results of previous
CCG epidemiologic investigations to test
specific hypotheses relating to childhood
brain tumors, HD, non-Hodgkin's lym-
phoma, andALL.
In future studies there will be more
integration of direct measurements of
exposure. While important associations can
be identified using self-reported informa-
tion obtained through interviews, it is rec-
ognized that there are limitations inherent
in data collected in this manner.
Accordingly, whenever possible, there will
be expanded use ofmore direct measures of
exposure. In the current leukemia studies,
direct measurements are being made of
electromagnetic field radiation, indoor
radon, and pesticide residues, PAH, and
heavy metals from house dust. While rec-
ognizing the financial and logistical issues
involved in these types of measurements,
experience to date clearly indicates the
utility and feasibility of this approach
within CCG.
When investigating etiologic hypothe-
ses, studies of childhood cancer must be
prepared to assess the potential role ofbio-
logic data, particularly in combination
with exposure data. With regard to the
conduct ofepidemiologic studies, one of
the many strengths ofutilizing the cooper-
ative clinical trials group is the availability
ofbiologic and/or clinical information on
ascertained cases. While the type of bio-
logic information is often disease- and pro-
tocol-specific, the information generally is
collected in a uniform manner at central-
ized resource laboratories. Previous CCG
epidemiology studies have incorporated
into the study design the use of data on
morphology, phenotype, and cytogenetics.
The current case-control study ofneurob-
lastoma uses the information on n-myc
amplification and ploidy. Other CCG
studies have included collecting specific
biologic data such as EBV. Depending on
the type of biologic data available, this
information can be used to stratify cases
into potentially more homogeneous sub-
groups (i.e., morphology, phenotype, etc.)
or to assess the biologic parameters as
potential risk factors, either solely or in
combination with other possible risk factors
(i.e., EBV, p53).
Since genetics, and possible genetic-
environment interactions, may be impor-
tant in the etiology ofchildhood cancers,
the CCG plans to expand the assessment of
family history. While most ofthe previous
CCG epidemiology studies have included
selected information on family history, the
majority have not been able to obtain a
detailed family pedigree. Recognizing the
potential importance offamily medical his-
tory, the Epidemiology Committee plans
to investigate the feasibility of systemati-
cally collecting more detailed data in future
studies. One of the major deterrents to
obtaining family history is the amount
time required. By building upon the expe-
rience of the CCG Genetics Registry, the
committee will investigate various
approaches to collecting family history
through self-administered and interview
formats.
Because ofthe large proportion ofchild-
hood cancer cases that are diagnosed and
treated at an institution affiliated with a
clinical trials cooperative group, it is possible
to investigate etiologic hypotheses in less
common childhood cancers. While from a
public health perspective it may be argued
that these rare forms ofmalignancies may
not warrant investigation, it is clear that
rare tumors have provided some of the
most important information concerning
cancer etiology (i.e., retinoblastoma). In
the near future the Epidemiology
Committee will consider studies of rare
childhood cancers including a) Burkitt's
lymphoma to investigate environmental
and genetic factors through a case-control
interview study that will correlate findings
with studies relating to evidence for EBV
infection and occurrence of chromosomal
translocations, and b) germ cell tumors to
investigate, in a case-control study design,
issues relating to congenital anomalies and
in uterohormone exposure.
Based on information compiled on the
distribution ofchildhood cancers registered
with the pediatric cooperative groups (11),
it has been estimated that over 95% of
patients diagnosed in the United States
before 10 years ofage could be ascertained.
Therefore, when appropriate, CCG plans
to promote the conduct ofintergroup epi-
demiologic studies to approximate a popu-
lation-based sample. This possibly would
allow the use ofalternative methodologic
approaches and promote interactions with
regional cancer registries.
Lastly, the epidemiologic and biologic
studies conducted by CCG and other
investigators are continually providing
information relating to the possible etiol-
ogy of childhood cancers. It is important
that this information be communicated in
the most effective manner to health care
professionals who interact with the popula-
tion of childhood cancer patients. The
CCG Epidemiology Committee, in collab-
oration with the CCG Nursing Commit-
tee, plans to provide a series ofeducational
programs to facilitate the exchange ofepi-
demiologic and etiologic information to
CCG investigators, including physicians,
nurses and data managers.
Summary
The experience ofthe CCG Epidemiology
Committee demonstrates the advantages in
conducting epidemiologic research within
an existing clinical trials network. The
detailed clinical and biologic data available
on patients diagnosed within the coopera-
tive groups facilitates the transfer ofstate-
of-the-art technology to epidemiologic
research. Discussions are underway in
CCG for future studies to correlate envi-
ronmental exposures with biologic parame-
ters including lIq23 mutations in
leukemia, ras gene mutations in childhood
AML, V-D-J recombinase in leukemia and
lymphoma, tyrosine kinase activity in ALL,
and parent oforigin of +21 in Down syn-
drome cases with leukemia. With the
emphasis on cancer biology within CCG
and other cooperative groups, the outlook
for further integrating biologic measures
into epidemiologic research in the future
looks very promising.
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